InsiderTrades

Form 4 for EXEL EXELIXIS, INC.

Accepted 2026-02-19 00:00:00 ET · period of report 2026-02-17 · accession 0000939767-26-000029 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2026-02-19 2026-02-17+ EXEL Smith Julie Dir M - OptEx $19.34 +106.5K 63.0K New +$2.06M
DM 2026-02-19 2026-02-17+ EXEL Smith Julie Dir S - Sale+OE $44.00 -106.5K 20.6K -84% -$4.69M
DM 2026-02-19 2026-02-17+ EXEL Smith Julie Dir M - OptEx $0.00 -106.5K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-02-18 M A 20,030 $21.69 40,620 D — — (F1) Includes 9,812 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
2 Common Common Stock 2026-02-18 S D 44,087 $44.50 20,590 D — — (F1) Includes 9,812 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
3 Common Common Stock 2026-02-18 M A 44,087 $19.39 64,677 D — — (F1) Includes 9,812 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
4 Common Common Stock 2026-02-17 S D 42,422 $43.33 20,590 D — — (F2) Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $44.30 to $44.44. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. (F1) Includes 9,812 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
5 Common Common Stock 2026-02-18 S D 20,030 $44.30 20,590 D — — (F1) Includes 9,812 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
6 Common Common Stock 2026-02-17 M A 42,422 $18.19 63,012 D — — (F1) Includes 9,812 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
7 Derivative Option (right to buy) 2026-02-17 M D 42,422 $0.00 0 D $18.19 · 2022-05-26 to 2029-05-25 42,422 Common Stock (F3) The option, representing the right to purchase a total of 42,422 shares of Common Stock, became fully exercisable on May 26, 2022.
8 Derivative Option (right to buy) 2026-02-18 M D 20,030 $0.00 0 D $21.69 · 2024-05-31 to 2031-05-30 20,030 Common Stock (F5) The option, representing the right to purchase a total of 20,030 shares of Common Stock, became fully exercisable on May 31, 2024.
9 Derivative Option (right to buy) 2026-02-18 M D 44,087 $0.00 0 D $19.39 · 2023-06-01 to 2030-05-31 44,087 Common Stock (F4) The option, representing the right to purchase a total of 44,087 shares of Common Stock, became fully exercisable on June 1, 2023.